Adjunctive Intravitreal Triamcinolone Acetonide for Exudative Retinal Detachment in Coats Disease
- 17 June 2021
- journal article
- research article
- Published by SAGE Publications in Journal of Vitreoretinal Diseases
- Vol. 6 (1) , 54-62
Abstract
This work aims to assess the value of intravitreal triamcinolone acetonide (IVTA) as an adjunctive therapy in advanced Coats disease with exudative retinal detachment (ERD). A retrospective review was conducted of patients with Coats disease stage 3 or higher who received IVTA to decrease subretinal fluid (SRF), facilitate retinal ablative therapy, and avoid surgical drainage. Primary outcomes were SRF resolution and avoidance of surgical SRF drainage. Seventeen eyes of 17 patients (mean, [SD] age, 3.9 [3.4] years) met the inclusion criteria. ERD configuration was bullous in 7 and shallow in 10 eyes. Following a single IVTA injection, ablative therapy was achieved after a mean (SD) of 2.1 (3.0) weeks. Complete SRF resolution was observed in 13 eyes (76.4%) after a mean of 1.3 IVTA injections and a mean of 2 (SD, 1.27) laser sessions, and none of these eyes required SRF drainage up to last follow-up (mean [SD], 50.5 [26.24] months). In 4 eyes with bullous ERD at presentation, SRF persisted (P = .015) despite additional measures including surgical drainage. Final visual acuity ranged from 20/100 to no light perception. Cataract developed in 12 of the 17 eyes (70.5%). None developed an increase in intraocular pressure at final follow-up. IVTA injection can be a helpful adjunctive modality to address SRF in advanced Coats disease. It may obviate the need to surgically drain SRF to effectively treat the condition, particularly when the ERD is not highly bullous.Keywords
This publication has 31 references indexed in Scilit:
- TRANSCLERAL DRAINAGE OF SUBRETINAL FLUID, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR, AND WIDE-FIELD IMAGING-GUIDED LASER IN COATS EXUDATIVE RETINAL DETACHMENTRetina, 2016
- CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF COATS DISEASE IN A SAUDI ARABIAN POPULATIONRetina, 2015
- Intravitreal Triamcinolone in Coats' DiseaseOphthalmology, 2012
- Vascular Endothelial Growth Factor Reduced and Connective Tissue Growth Factor Induced by Triamcinolone in ARPE19 Cells under Oxidative StressInvestigative Ophthalmology & Visual Science, 2005
- REVIEW: COATS DISEASERetina, 2002
- Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC‐II in exudative age‐related macular degenerationClinical & Experimental Ophthalmology, 2001
- Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial LectureAmerican Journal of Ophthalmology, 2001
- Classification and management of Coats disease: the 2000 Proctor LectureAmerican Journal of Ophthalmology, 2001
- Coats’ DiseaseOphthalmology, 1982
- Treatment of Coats' disease with photocoagulationGraefe's Archive for Clinical and Experimental Ophthalmology, 1976